Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck

J Bernier - Nature Clinical Practice Oncology, 2008 - nature.com
Patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
(SCCHN) have a poor prognosis, particularly those whose disease has progressed on …
被引用次数：43 相关文章

Drug insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck

J Bernier - Nature Clinical Practice Oncology, 2008 - go.gale.com
Patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
(SCCHN) have a poor prognosis, particularly those whose disease has progressed on …

Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck.

J Bernier - Nature Clinical practice. Oncology, 2008 - europepmc.org
Patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
(SCCHN) have a poor prognosis, particularly those whose disease has progressed on …

Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck

J Bernier - Nature clinical practice. Oncology, 2008 - pubmed.ncbi.nlm.nih.gov
Patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
(SCCHN) have a poor prognosis, particularly those whose disease has progressed on …

[引用][C] Drug Insight: cetuximab in the treatment of recurrent and metastatic squamous cell carcinoma of the head and neck

J Bernier - Nature Reviews. Clinical Oncology, 2008 - Nature Publishing Group